A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 47/48 (2006.01) A61P 37/06 (2006.01)
Patent
CA 2755133
Disclosed are compositions of matter having an amino acid sequence of SEQ ID NO:4, or a pharmaceutically ac-ceptable salt thereof, including embodiments comprising a toxin peptide analog related to ShK, HmK, and AETX-K and pharma-ceutical compositions or medicaments containing them along with a pharmaceutically acceptable carrier. Some embodiments in-clude a half-life extending moiety. Also disclosed are a method of preventing or mitigating a relapse of a symptom of multiple sclerosis and a method of treating an autoimmune disorder using the compositions.
L'invention concerne des compositions de substance qui a une séquence d'acides aminés de SEQ ID NO:4, ou d'un de ses sels pharmaceutiquement acceptables, notamment des modes de réalisation comprenant un analogue de peptide de toxine apparenté à ShK, HmK, et AETX-K et des compositions pharmaceutiques ou des médicaments les contenant, combiné à un support pharmaceutiquement acceptable. Certains modes de réalisation comprennent une partie prolongeant la demi-vie. L'invention concerne également un procédé de prévention ou d'atténuation du retour d'un symptôme de sclérose en plaques et un procédé de traitement d'une affection auto-immune au moyen de ces compositions.
Arora Taruna
Belouski Edward J.
Boone Thomas C.
Gegg Colin V.
Hu Shaw-Fen Sylvia
Amgen Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Selective and potent peptide inhibitors of kv1.3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective and potent peptide inhibitors of kv1.3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective and potent peptide inhibitors of kv1.3 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1749801